We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current ALCLS market cap is 60.19M. The company's latest EPS is USD -0.8013 and P/E is -1.56.
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 82.46M | 67.58M | 27.67M | 9.24M | 50.07M |
| Operating Income | -85.44M | -130.68M | -110.85M | -108.2M | -59.55M |
| Net Income | -81.07M | -114.2M | -106.14M | -101.06M | -36.76M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 469.47M | 382.08M | 261.22M | 334.27M | 383.54M |
| Total Liabilities | 160.63M | 145.6M | 135.28M | 249.58M | 252.51M |
| Total Equity | 308.85M | 236.47M | 125.94M | 84.7M | 131.03M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -80.26M | -104.56M | -87.44M | -24.75M | 22.99M |
| Investing | -54.34M | 7.28M | -2.76M | -15.51M | -102.81M |
| Financing | 27.32M | 47.53M | 1.15M | 82.86M | 89.11M |
| Market Cap | 60.19M |
| Price to Earnings Ratio | -1.56 |
| Price to Sales Ratio | 1.15 |
| Price to Cash Ratio | 0.4 |
| Price to Book Ratio | 0.44 |
| Dividend Yield | - |
| Shares Outstanding | 45.87M |
| Average Volume (1 week) | 97.79k |
| Average Volume (1 Month) | 225.69k |
| 52 Week Change | -45.45% |
| 52 Week High | 3.025 |
| 52 Week Low | 1.012 |
| Spread (Intraday) | 0.03 (2.27%) |
| Company Name | Cellectis Nom Eo 05 |
| Address |
8 rue de la croix- jarry paris, paris 75013 |
| Website | https://www.cellectis.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
